Clinical Efficacy of a Non-Invasive Measure of Intracranial Pressure

NCT03212976 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2024-12-05

No results posted yet for this study

Summary

This study is designed to evaluate the accuracy of a non-invasive method phase-contrast magnetic resonance imaging (MR-ICP) for assessing intracranial pressure (Phase 1).

To perform second phase contrast imaging to evaluate the patency and flow of ventricular catheters after MR-ICP imaging (Phase 2).

Conditions

  • Intracranial Pathology
  • Intracranial Hypertension

Interventions

PROCEDURE

Phase contrast magnetic resonance imaging

Phase-contrast magnetic resonance imaging will be done to assess intracranial pressure

Sponsors & Collaborators

  • University of Miami

    lead OTHER

Principal Investigators

  • Ronald Benveniste, MD, PhD · University of Miami

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-26
Primary Completion
2020-10-15
Completion
2020-10-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03212976 on ClinicalTrials.gov